Cardiawave appoints Olivier Pierron as its Chief Executive Officer
By bertrand
16/04/2024 Cardiawave appoints Olivier Pierronas its Chief Executive Officer DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
16/04/2024 Cardiawave appoints Olivier Pierronas its Chief Executive Officer DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
15/04/2024 Cardiawave annonce la nomination d’Olivier Pierronen tant que Directeur Général DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
05/04/2024 Cardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis at the 73rd Annual Conference of the ACC – April 6–8, 2024, Atlanta (GA) DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
05/04/2024 Cardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024 DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
Cardiawave featured in a recent article by Cardiovascular Business ! December 14th 2023 🚀 Cardiawave was featured in a recent article by Cardiovascular Business, highlighting the potential of our non-invasive ultrasound therapy device for the treatment of aortic stenosis to become part of current and future medical solutions ! Thanks to Cardiovascular Business for this … Continued
By bertrand
Cardiawave featured in ESC TV Today! November 27th 2023 🔬Cardiawave is thrilled to share ESC TV Today’s video spotlighting its recently published clinical study results in The Lancet! The 40 patients suffering from severe symptomatic aortic stenosis treated by the medtech innovative Non-Invasive Ultrasound Therapy (NIUT) experienced an improvement in their quality of life.Our team’s … Continued
By bertrand
Cardiawave’s First-in-Human clinical studies results published in The Lancet! November 17th 2023 📢 Cardiawave is proud to announce the publication of its First-In-Human (FIH) clinical studies results with 40 patients suffering from aortic stenosis treated with its innovative Non-Invasive Ultrasound Therapy (NIUT) device in The Lancet journal! 🚀 📖 The Lancet is a prestigious medical journal, … Continued
By bertrand
14/11/2023 Cardiawave announces the publication in The Lancet of First-In-Human clinical studies results with 40 aortic stenosis patients treated with its innovative Non-Invasive Ultrasound Therapy (NIUT) DOWNLOAD THE PRESS RELEASE > << Press Release
By bertrand
14/11/2023 Cardiawave annonce la publication dans The Lancet des résultats de ses études cliniques « First-in-Human » portant sur 40 patients souffrant de Rétrécissement Aortique Calcifié traités par sa thérapie innovante non-invasive par ultrasons DOWNLOAD THE PRESS RELEASE > << Press Release